Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

559.00INR
24 May 2019
Change (% chg)

Rs-3.35 (-0.60%)
Prev Close
Rs562.35
Open
Rs564.20
Day's High
Rs567.00
Day's Low
Rs555.00
Volume
707,301
Avg. Vol
604,627
52-wk High
Rs711.90
52-wk Low
Rs505.50

Gorthi, Sridhar 

Mr. Sridhar Gorthi serves as Non-Executive Independent Director of Glenmark Pharmaceuticals Ltd. Mr. Gorthi is a partner in the Mumbai office of Trilegal and his areas of expertise include M&A, joint ventures, private equity and venture capital. He has been actively involved in several high-profile cross-border transactions. Apart from representing several international clients on M&A in India, he has also advised Indian companies about outbound M&A transactions in jurisdiction such as the UK, the US, South Africa, Argentina, Indonesia and Sri Lanka.

Basic Compensation

Total Annual Compensation, INR 1,600,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 1,600,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018